Melbourne, 9 August 2023: Infectious disease therapy and vaccine development company BioDiem Ltd today announced a change to its board of directors with the retirement of Mr Fergus Mak Po Kan who joined the BioDiem board in September 2021.
BioDiem’s chairman Mr Damien Hannes said “We would like to express the company’s gratitude for the contribution Mr Fergus Mak Po Kan has made over the past two years since he joined the board and wish him well in his retirement.”
